BERGER FRANKLIN M
SEC insider (Form 3/4/5 filer). CIK 0001273885. Director at Retension Pharmaceuticals, Inc. (RTSN) and 3 other issuers. 20 reported Form 4/5 transactions since Sep 2024; latest on Oct 13, 2026. Located in FALLS CHURCH, VA.
Companies BERGER FRANKLIN M has filed insider reports for
- Retension Pharmaceuticals, Inc. (RTSN): Director
- Atea Pharmaceuticals, Inc. (AVIR): Director
- Kezar Life Sciences, Inc. (KZR): Director
- ESSA Pharma Inc. (EPIX): Director
BERGER FRANKLIN M
CIK: 0001273885
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (20 total)
- Oct 13, 2026RTSN
Retension Pharmaceuticals, Inc.
ConversionDirect12.5K shares- - Oct 13, 2026RTSN
Retension Pharmaceuticals, Inc.
PurchaseIndirect10K shares at avg. $12.00$120K - Oct 8, 2026RTSN
Retension Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
5.6K shares- - Jun 18, 2026AVIR
Atea Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
37.7K shares- - Jun 18, 2026AVIR
Atea Pharmaceuticals, Inc.
ExerciseDirect29.6K shares- - Jun 18, 2026AVIR
Atea Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
26.7K shares- - May 11, 2026KZR
Kezar Life Sciences, Inc.
DispositionDirectStock Option (right to buy)
3.5K shares- - May 11, 2026KZR
Kezar Life Sciences, Inc.
Tender OfferDirect89.1K shares- - May 11, 2026KZR
Kezar Life Sciences, Inc.
DispositionDirectStock Option (right to buy)
5K shares- - May 11, 2026KZR
Kezar Life Sciences, Inc.
DispositionDirectStock Option (right to buy)
5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 13, 2026 |  RTSN Retension Pharmaceuticals, Inc. | Conversion | 12,517 | - | $0 | Direct |
| Oct 13, 2026 | RTSN Retension Pharmaceuticals, Inc. | Purchase | 10,000 | $12.00 | $120,000 | Indirect |
| Oct 8, 2026 | RTSN Retension Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 5,636 | - | - | Direct |
| Jun 18, 2026 |  AVIR Atea Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 37,700 | - | - | Direct |
| Jun 18, 2026 | AVIR Atea Pharmaceuticals, Inc. | Exercise | 29,600 | - | $0 | Direct |
| Jun 18, 2026 | AVIR Atea Pharmaceuticals, Inc. | Award Restricted Stock Units | 26,700 | - | - | Direct |
| May 11, 2026 |  KZR Kezar Life Sciences, Inc. | Disposition Stock Option (right to buy) | 3,500 | - | - | Direct |
| May 11, 2026 | KZR Kezar Life Sciences, Inc. | Tender Offer | 89,069 | - | $0 | Direct |
| May 11, 2026 | KZR Kezar Life Sciences, Inc. | Disposition Stock Option (right to buy) | 5,000 | - | - | Direct |
| May 11, 2026 | KZR Kezar Life Sciences, Inc. | Disposition Stock Option (right to buy) | 5,000 | - | - | Direct |
1-10 of 20 transactions